nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—UGT1A1—Etoposide—sarcoma	0.28	0.315	CbGbCtD
Indacaterol—CYP3A4—Thiotepa—sarcoma	0.123	0.138	CbGbCtD
Indacaterol—ABCB1—Dactinomycin—sarcoma	0.0985	0.111	CbGbCtD
Indacaterol—ABCB1—Mitoxantrone—sarcoma	0.0881	0.0991	CbGbCtD
Indacaterol—ABCB1—Vincristine—sarcoma	0.0607	0.0682	CbGbCtD
Indacaterol—ABCB1—Etoposide—sarcoma	0.0556	0.0625	CbGbCtD
Indacaterol—CYP3A4—Mitoxantrone—sarcoma	0.0528	0.0594	CbGbCtD
Indacaterol—ABCB1—Doxorubicin—sarcoma	0.0379	0.0426	CbGbCtD
Indacaterol—CYP3A4—Vincristine—sarcoma	0.0363	0.0409	CbGbCtD
Indacaterol—CYP3A4—Etoposide—sarcoma	0.0333	0.0375	CbGbCtD
Indacaterol—CYP3A4—Doxorubicin—sarcoma	0.0227	0.0255	CbGbCtD
Indacaterol—Myocardial ischaemia—Mitoxantrone—sarcoma	0.00245	0.0221	CcSEcCtD
Indacaterol—Musculoskeletal pain—Vincristine—sarcoma	0.00205	0.0184	CcSEcCtD
Indacaterol—Chest discomfort—Etoposide—sarcoma	0.00185	0.0167	CcSEcCtD
Indacaterol—Hypokalaemia—Mitoxantrone—sarcoma	0.0013	0.0117	CcSEcCtD
Indacaterol—Hyperglycaemia—Thiotepa—sarcoma	0.00129	0.0116	CcSEcCtD
Indacaterol—Pneumonia—Thiotepa—sarcoma	0.00128	0.0116	CcSEcCtD
Indacaterol—Infestation NOS—Thiotepa—sarcoma	0.00127	0.0115	CcSEcCtD
Indacaterol—Infestation—Thiotepa—sarcoma	0.00127	0.0115	CcSEcCtD
Indacaterol—Pneumonia—Dactinomycin—sarcoma	0.00127	0.0115	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.00115	0.0103	CcSEcCtD
Indacaterol—Pneumonia—Vincristine—sarcoma	0.00114	0.0102	CcSEcCtD
Indacaterol—Connective tissue disorder—Thiotepa—sarcoma	0.00112	0.0101	CcSEcCtD
Indacaterol—Hyperglycaemia—Mitoxantrone—sarcoma	0.00111	0.01	CcSEcCtD
Indacaterol—Pneumonia—Mitoxantrone—sarcoma	0.00111	0.00998	CcSEcCtD
Indacaterol—Cardiac disorder—Thiotepa—sarcoma	0.00106	0.00957	CcSEcCtD
Indacaterol—Immune system disorder—Thiotepa—sarcoma	0.00103	0.00931	CcSEcCtD
Indacaterol—Sinusitis—Mitoxantrone—sarcoma	0.00103	0.0093	CcSEcCtD
Indacaterol—Mediastinal disorder—Thiotepa—sarcoma	0.00103	0.00929	CcSEcCtD
Indacaterol—Bronchospasm—Etoposide—sarcoma	0.00101	0.0091	CcSEcCtD
Indacaterol—Connective tissue disorder—Vincristine—sarcoma	0.000997	0.00898	CcSEcCtD
Indacaterol—Malnutrition—Thiotepa—sarcoma	0.000996	0.00897	CcSEcCtD
Indacaterol—Cardiac disorder—Vincristine—sarcoma	0.000942	0.00848	CcSEcCtD
Indacaterol—Musculoskeletal pain—Epirubicin—sarcoma	0.000929	0.00837	CcSEcCtD
Indacaterol—Pneumonia—Etoposide—sarcoma	0.000921	0.0083	CcSEcCtD
Indacaterol—Anaemia—Thiotepa—sarcoma	0.000921	0.00829	CcSEcCtD
Indacaterol—Infestation NOS—Etoposide—sarcoma	0.000916	0.00825	CcSEcCtD
Indacaterol—Infestation—Etoposide—sarcoma	0.000916	0.00825	CcSEcCtD
Indacaterol—Mediastinal disorder—Vincristine—sarcoma	0.000914	0.00824	CcSEcCtD
Indacaterol—Anaemia—Dactinomycin—sarcoma	0.000914	0.00823	CcSEcCtD
Indacaterol—Cough—Thiotepa—sarcoma	0.000869	0.00783	CcSEcCtD
Indacaterol—Musculoskeletal pain—Doxorubicin—sarcoma	0.000859	0.00774	CcSEcCtD
Indacaterol—Myalgia—Thiotepa—sarcoma	0.000848	0.00764	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000842	0.00759	CcSEcCtD
Indacaterol—Myalgia—Dactinomycin—sarcoma	0.000842	0.00758	CcSEcCtD
Indacaterol—Anaemia—Vincristine—sarcoma	0.000816	0.00736	CcSEcCtD
Indacaterol—Infection—Thiotepa—sarcoma	0.000808	0.00728	CcSEcCtD
Indacaterol—Infection—Dactinomycin—sarcoma	0.000802	0.00722	CcSEcCtD
Indacaterol—Nervous system disorder—Thiotepa—sarcoma	0.000797	0.00718	CcSEcCtD
Indacaterol—Anaemia—Mitoxantrone—sarcoma	0.000795	0.00716	CcSEcCtD
Indacaterol—Vertigo—Vincristine—sarcoma	0.000794	0.00715	CcSEcCtD
Indacaterol—Tachycardia—Thiotepa—sarcoma	0.000793	0.00715	CcSEcCtD
Indacaterol—Skin disorder—Thiotepa—sarcoma	0.00079	0.00711	CcSEcCtD
Indacaterol—Diabetes mellitus—Epirubicin—sarcoma	0.000766	0.0069	CcSEcCtD
Indacaterol—Cardiac disorder—Etoposide—sarcoma	0.000763	0.00687	CcSEcCtD
Indacaterol—Myalgia—Vincristine—sarcoma	0.000752	0.00678	CcSEcCtD
Indacaterol—Cough—Mitoxantrone—sarcoma	0.000751	0.00676	CcSEcCtD
Indacaterol—Immune system disorder—Etoposide—sarcoma	0.000742	0.00669	CcSEcCtD
Indacaterol—Mediastinal disorder—Etoposide—sarcoma	0.000741	0.00667	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000741	0.00667	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000735	0.00662	CcSEcCtD
Indacaterol—Chest pain—Mitoxantrone—sarcoma	0.000732	0.0066	CcSEcCtD
Indacaterol—Myalgia—Mitoxantrone—sarcoma	0.000732	0.0066	CcSEcCtD
Indacaterol—Paraesthesia—Thiotepa—sarcoma	0.00073	0.00658	CcSEcCtD
Indacaterol—Infection—Vincristine—sarcoma	0.000716	0.00645	CcSEcCtD
Indacaterol—Diabetes mellitus—Doxorubicin—sarcoma	0.000709	0.00638	CcSEcCtD
Indacaterol—Nervous system disorder—Vincristine—sarcoma	0.000707	0.00637	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Thiotepa—sarcoma	0.000702	0.00632	CcSEcCtD
Indacaterol—Infection—Mitoxantrone—sarcoma	0.000697	0.00628	CcSEcCtD
Indacaterol—Muscle spasms—Etoposide—sarcoma	0.000688	0.0062	CcSEcCtD
Indacaterol—Tachycardia—Mitoxantrone—sarcoma	0.000685	0.00617	CcSEcCtD
Indacaterol—Skin disorder—Mitoxantrone—sarcoma	0.000682	0.00614	CcSEcCtD
Indacaterol—Anaemia—Etoposide—sarcoma	0.000661	0.00596	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Vincristine—sarcoma	0.000657	0.00592	CcSEcCtD
Indacaterol—Paraesthesia—Vincristine—sarcoma	0.000647	0.00583	CcSEcCtD
Indacaterol—Vertigo—Etoposide—sarcoma	0.000643	0.00579	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00064	0.00576	CcSEcCtD
Indacaterol—Paraesthesia—Mitoxantrone—sarcoma	0.00063	0.00568	CcSEcCtD
Indacaterol—Dyspnoea—Mitoxantrone—sarcoma	0.000626	0.00564	CcSEcCtD
Indacaterol—Cough—Etoposide—sarcoma	0.000624	0.00563	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Vincristine—sarcoma	0.000622	0.00561	CcSEcCtD
Indacaterol—Chest pain—Etoposide—sarcoma	0.000609	0.00549	CcSEcCtD
Indacaterol—Hypokalaemia—Epirubicin—sarcoma	0.000606	0.00546	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000605	0.00545	CcSEcCtD
Indacaterol—Hypersensitivity—Thiotepa—sarcoma	0.000599	0.0054	CcSEcCtD
Indacaterol—Nasopharyngitis—Epirubicin—sarcoma	0.000596	0.00537	CcSEcCtD
Indacaterol—Hypersensitivity—Dactinomycin—sarcoma	0.000594	0.00536	CcSEcCtD
Indacaterol—Infection—Etoposide—sarcoma	0.00058	0.00523	CcSEcCtD
Indacaterol—Asthma—Epirubicin—sarcoma	0.000576	0.00519	CcSEcCtD
Indacaterol—Pruritus—Thiotepa—sarcoma	0.000575	0.00518	CcSEcCtD
Indacaterol—Tachycardia—Etoposide—sarcoma	0.00057	0.00513	CcSEcCtD
Indacaterol—Skin disorder—Etoposide—sarcoma	0.000567	0.00511	CcSEcCtD
Indacaterol—Hypokalaemia—Doxorubicin—sarcoma	0.000561	0.00505	CcSEcCtD
Indacaterol—Angina pectoris—Epirubicin—sarcoma	0.000561	0.00505	CcSEcCtD
Indacaterol—Nasopharyngitis—Doxorubicin—sarcoma	0.000551	0.00496	CcSEcCtD
Indacaterol—Dizziness—Thiotepa—sarcoma	0.000538	0.00484	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Epirubicin—sarcoma	0.000535	0.00482	CcSEcCtD
Indacaterol—Asthma—Doxorubicin—sarcoma	0.000533	0.0048	CcSEcCtD
Indacaterol—Hypersensitivity—Vincristine—sarcoma	0.000531	0.00479	CcSEcCtD
Indacaterol—Paraesthesia—Etoposide—sarcoma	0.000524	0.00472	CcSEcCtD
Indacaterol—Dyspnoea—Etoposide—sarcoma	0.000521	0.00469	CcSEcCtD
Indacaterol—Hyperglycaemia—Epirubicin—sarcoma	0.000519	0.00468	CcSEcCtD
Indacaterol—Angina pectoris—Doxorubicin—sarcoma	0.000519	0.00467	CcSEcCtD
Indacaterol—Hypersensitivity—Mitoxantrone—sarcoma	0.000517	0.00466	CcSEcCtD
Indacaterol—Pneumonia—Epirubicin—sarcoma	0.000516	0.00465	CcSEcCtD
Indacaterol—Infestation NOS—Epirubicin—sarcoma	0.000513	0.00462	CcSEcCtD
Indacaterol—Infestation—Epirubicin—sarcoma	0.000513	0.00462	CcSEcCtD
Indacaterol—Rash—Thiotepa—sarcoma	0.000513	0.00462	CcSEcCtD
Indacaterol—Dermatitis—Thiotepa—sarcoma	0.000512	0.00461	CcSEcCtD
Indacaterol—Headache—Thiotepa—sarcoma	0.000509	0.00459	CcSEcCtD
Indacaterol—Rash—Dactinomycin—sarcoma	0.000509	0.00458	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Etoposide—sarcoma	0.000504	0.00454	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000495	0.00446	CcSEcCtD
Indacaterol—Nausea—Thiotepa—sarcoma	0.000483	0.00435	CcSEcCtD
Indacaterol—Sinusitis—Epirubicin—sarcoma	0.000482	0.00434	CcSEcCtD
Indacaterol—Hyperglycaemia—Doxorubicin—sarcoma	0.00048	0.00433	CcSEcCtD
Indacaterol—Nausea—Dactinomycin—sarcoma	0.000479	0.00432	CcSEcCtD
Indacaterol—Pneumonia—Doxorubicin—sarcoma	0.000478	0.0043	CcSEcCtD
Indacaterol—Dizziness—Vincristine—sarcoma	0.000477	0.00429	CcSEcCtD
Indacaterol—Infestation NOS—Doxorubicin—sarcoma	0.000475	0.00428	CcSEcCtD
Indacaterol—Infestation—Doxorubicin—sarcoma	0.000475	0.00428	CcSEcCtD
Indacaterol—Rash—Vincristine—sarcoma	0.000455	0.0041	CcSEcCtD
Indacaterol—Dermatitis—Vincristine—sarcoma	0.000454	0.00409	CcSEcCtD
Indacaterol—Oedema peripheral—Epirubicin—sarcoma	0.000454	0.00409	CcSEcCtD
Indacaterol—Connective tissue disorder—Epirubicin—sarcoma	0.000453	0.00408	CcSEcCtD
Indacaterol—Headache—Vincristine—sarcoma	0.000452	0.00407	CcSEcCtD
Indacaterol—Sinusitis—Doxorubicin—sarcoma	0.000446	0.00401	CcSEcCtD
Indacaterol—Rash—Mitoxantrone—sarcoma	0.000443	0.00399	CcSEcCtD
Indacaterol—Dermatitis—Mitoxantrone—sarcoma	0.000442	0.00398	CcSEcCtD
Indacaterol—Headache—Mitoxantrone—sarcoma	0.00044	0.00396	CcSEcCtD
Indacaterol—Hypersensitivity—Etoposide—sarcoma	0.00043	0.00388	CcSEcCtD
Indacaterol—Nausea—Vincristine—sarcoma	0.000428	0.00386	CcSEcCtD
Indacaterol—Cardiac disorder—Epirubicin—sarcoma	0.000428	0.00385	CcSEcCtD
Indacaterol—Oedema peripheral—Doxorubicin—sarcoma	0.00042	0.00378	CcSEcCtD
Indacaterol—Connective tissue disorder—Doxorubicin—sarcoma	0.000419	0.00377	CcSEcCtD
Indacaterol—Nausea—Mitoxantrone—sarcoma	0.000417	0.00376	CcSEcCtD
Indacaterol—Immune system disorder—Epirubicin—sarcoma	0.000416	0.00375	CcSEcCtD
Indacaterol—Mediastinal disorder—Epirubicin—sarcoma	0.000415	0.00374	CcSEcCtD
Indacaterol—Pruritus—Etoposide—sarcoma	0.000413	0.00372	CcSEcCtD
Indacaterol—Malnutrition—Epirubicin—sarcoma	0.000401	0.00361	CcSEcCtD
Indacaterol—Cardiac disorder—Doxorubicin—sarcoma	0.000396	0.00356	CcSEcCtD
Indacaterol—Dizziness—Etoposide—sarcoma	0.000386	0.00348	CcSEcCtD
Indacaterol—Muscle spasms—Epirubicin—sarcoma	0.000386	0.00347	CcSEcCtD
Indacaterol—Immune system disorder—Doxorubicin—sarcoma	0.000385	0.00347	CcSEcCtD
Indacaterol—Mediastinal disorder—Doxorubicin—sarcoma	0.000384	0.00346	CcSEcCtD
Indacaterol—Malnutrition—Doxorubicin—sarcoma	0.000371	0.00334	CcSEcCtD
Indacaterol—Anaemia—Epirubicin—sarcoma	0.000371	0.00334	CcSEcCtD
Indacaterol—Rash—Etoposide—sarcoma	0.000368	0.00332	CcSEcCtD
Indacaterol—Dermatitis—Etoposide—sarcoma	0.000368	0.00331	CcSEcCtD
Indacaterol—Headache—Etoposide—sarcoma	0.000366	0.0033	CcSEcCtD
Indacaterol—Vertigo—Epirubicin—sarcoma	0.00036	0.00325	CcSEcCtD
Indacaterol—Muscle spasms—Doxorubicin—sarcoma	0.000357	0.00321	CcSEcCtD
Indacaterol—Palpitations—Epirubicin—sarcoma	0.000354	0.00319	CcSEcCtD
Indacaterol—Cough—Epirubicin—sarcoma	0.00035	0.00315	CcSEcCtD
Indacaterol—Nausea—Etoposide—sarcoma	0.000347	0.00313	CcSEcCtD
Indacaterol—Anaemia—Doxorubicin—sarcoma	0.000343	0.00309	CcSEcCtD
Indacaterol—Myalgia—Epirubicin—sarcoma	0.000341	0.00308	CcSEcCtD
Indacaterol—Chest pain—Epirubicin—sarcoma	0.000341	0.00308	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000339	0.00306	CcSEcCtD
Indacaterol—Dry mouth—Epirubicin—sarcoma	0.000334	0.00301	CcSEcCtD
Indacaterol—Vertigo—Doxorubicin—sarcoma	0.000333	0.003	CcSEcCtD
Indacaterol—Palpitations—Doxorubicin—sarcoma	0.000328	0.00295	CcSEcCtD
Indacaterol—Infection—Epirubicin—sarcoma	0.000325	0.00293	CcSEcCtD
Indacaterol—Cough—Doxorubicin—sarcoma	0.000324	0.00292	CcSEcCtD
Indacaterol—Nervous system disorder—Epirubicin—sarcoma	0.000321	0.00289	CcSEcCtD
Indacaterol—Tachycardia—Epirubicin—sarcoma	0.000319	0.00288	CcSEcCtD
Indacaterol—Skin disorder—Epirubicin—sarcoma	0.000318	0.00286	CcSEcCtD
Indacaterol—Myalgia—Doxorubicin—sarcoma	0.000316	0.00285	CcSEcCtD
Indacaterol—Chest pain—Doxorubicin—sarcoma	0.000316	0.00285	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000314	0.00283	CcSEcCtD
Indacaterol—Dry mouth—Doxorubicin—sarcoma	0.000309	0.00278	CcSEcCtD
Indacaterol—Infection—Doxorubicin—sarcoma	0.000301	0.00271	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000298	0.00269	CcSEcCtD
Indacaterol—Nervous system disorder—Doxorubicin—sarcoma	0.000297	0.00268	CcSEcCtD
Indacaterol—Tachycardia—Doxorubicin—sarcoma	0.000296	0.00266	CcSEcCtD
Indacaterol—Skin disorder—Doxorubicin—sarcoma	0.000294	0.00265	CcSEcCtD
Indacaterol—Paraesthesia—Epirubicin—sarcoma	0.000294	0.00265	CcSEcCtD
Indacaterol—Dyspnoea—Epirubicin—sarcoma	0.000292	0.00263	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Epirubicin—sarcoma	0.000283	0.00255	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000276	0.00249	CcSEcCtD
Indacaterol—Paraesthesia—Doxorubicin—sarcoma	0.000272	0.00245	CcSEcCtD
Indacaterol—Dyspnoea—Doxorubicin—sarcoma	0.00027	0.00243	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000261	0.00236	CcSEcCtD
Indacaterol—Hypersensitivity—Epirubicin—sarcoma	0.000241	0.00217	CcSEcCtD
Indacaterol—Pruritus—Epirubicin—sarcoma	0.000232	0.00209	CcSEcCtD
Indacaterol—Hypersensitivity—Doxorubicin—sarcoma	0.000223	0.00201	CcSEcCtD
Indacaterol—Dizziness—Epirubicin—sarcoma	0.000216	0.00195	CcSEcCtD
Indacaterol—Pruritus—Doxorubicin—sarcoma	0.000214	0.00193	CcSEcCtD
Indacaterol—Rash—Epirubicin—sarcoma	0.000206	0.00186	CcSEcCtD
Indacaterol—Dermatitis—Epirubicin—sarcoma	0.000206	0.00186	CcSEcCtD
Indacaterol—Headache—Epirubicin—sarcoma	0.000205	0.00185	CcSEcCtD
Indacaterol—Dizziness—Doxorubicin—sarcoma	0.0002	0.0018	CcSEcCtD
Indacaterol—Nausea—Epirubicin—sarcoma	0.000194	0.00175	CcSEcCtD
Indacaterol—Rash—Doxorubicin—sarcoma	0.000191	0.00172	CcSEcCtD
Indacaterol—Dermatitis—Doxorubicin—sarcoma	0.000191	0.00172	CcSEcCtD
Indacaterol—Headache—Doxorubicin—sarcoma	0.00019	0.00171	CcSEcCtD
Indacaterol—Nausea—Doxorubicin—sarcoma	0.00018	0.00162	CcSEcCtD
